申请人:SUMITOMO PHARMACEUTICALS COMPANY, LIMITED
公开号:EP0260655A2
公开(公告)日:1988-03-23
A compound of the formula:
wherein Y is a free or esterified carboxyl group, or a group of the formula:
(wherein Ra and Rb are each independently a hydrogen atom, a C₁-C₄ alkyl group, a C₃-C₇ cycloalkyl group, a benzyl group, a phenyl group, a phenyl group substituted with a halogen atom or a C₁-C₄ alkyl group, or, when taken together with the adjacent nitrogen atom, they represent a 5 to 7 membered saturated heterocyclic group); R¹ is a C₁-C₁₂ alkyl group, a C₂-C₁₂ alkenyl group, a C₂-C₁₂ alkynyl group, a C₃-C₁₀ cycloalkyl group, a C₄-C₁₀ cycloalkenyl group, a hydroxy C₁-C₁₂ alkyl group, an C₁-C₁₂ alkyl group substituted with a group of the formula:
(wherein Rc and Rd are each independently a hydrogen atom, or a C₁-C₄ alkyl group), a C₃-C₁₀ heterocyclic group, a phenyl group optionally substituted with one to three substituents selected from the group consisting of halogen atom, hydroxyl group, C₁-C₄ alkyl group, trifluoromethyl group, C₁-C₄ alkoxy group, and group of the formula:
wherein Rc and Rd are as defined above) or a group of the formula:
A-B
[wherein A is a C₁-C₇ alkylene chain and B is a C₃-C₁₀ cycloalkyl group, a C₄-C₁₀ cycloalkenyl group, a C₁-C₁₂ alkoxy group, a C₁-C₁₂ alkylthio group, a C₃-C₁₀ cycloalkoxy group, a C₄-C₁₀ cycloalkenyloxy group, a C₃-C₁₀ heterocyclic group, or a phenyl or phenoxy group optionally substituted with one to three substituents selected from the group consisting of halogen atom, hydroxy group, C₁-C₄ alkyl group, group of the formula:
(wherein Rc and Rd are as defined above), trifluoromethyl group, C₁-C₄ alkylthio group and C₁-C₄ alkoxy group] or a pharmaceutically acceptable salt thereof. Said compound has potent anti-leucotriene B₄ action, and is useful in the treatment of inflammatory states or immunological disorders.
式中的化合物
其中 Y 是游离的或酯化的羧基,或者是式中的基团:
(其中 Ra 和 Rb 各自独立地为氢原子、C₁-C₄ 烷基、C₃-C₇ 环烷基、苄基、苯基、被卤素原子或 C₁-C₄烷基取代的苯基,或当与相邻的氮原子合在一起时,它们代表 5 至 7 个成员的饱和杂环基团);R¹ 是 C₁-C₁₂ 烷基、C₂-C₁₂ 烯基、C₂-C₁₂ 炔基、C₃-C₁₀ 环烷基、C₄-C₁₀环烷基、C₁-C₁₂烷基羟基、被式中基团取代的 C₁-C₁₂烷基:
(其中 Rc 和 Rd 各自独立地为氢原子或 C₁-C₄ 烷基)、C₃-C₁₀ 杂环基团、可任选被一至三个取代基取代的苯基,这些取代基可选自由卤素原子、羟基、C₁-C₄ 烷基、三
氟甲基、C₁-C₄ 烷氧基和式中的基团组成的组:
其中 Rc 和 Rd 如上定义)或式中的基团:
A-B
[其中 A 是 C₁-C₇ 亚烷基链,B 是 C₃-C₁₀ 环烷基、C₄-C₁₀ 环烯基、C₁-C₁₂烷氧基、C₁-C₁₂烷
硫基、C₃-C₁₀ 环烷氧基、C₄-C₁₀ 环烯氧基、C₃-C₁₀杂环基团,或可任选被一至三个取代基取代的苯基或苯氧基团,这些取代基可选自卤素原子、羟基、C₁-C₄烷基、式中的基团:
(其中 Rc 和 Rd 如上定义)、三
氟甲基、C₁-C₄ 烷
硫基和 C₁-C₄ 烷氧基]或其药学上可接受的盐。所述化合物具有强效的抗
白三烯 B₄ 作用,可用于治疗炎症状态或免疫紊乱。